Table 1.
Characteristics of Clinic Population (N = 163)
| Characteristic | N | % |
|---|---|---|
| Age | ||
| <40 | 63 | 38% |
| 40–65 | 63 | 38% |
| >65 | 37 | 23% |
| Sex | ||
| Male | 84 | 52% |
| Female | 79 | 48% |
| Race | ||
| White | 135 | 83% |
| Black or African American | 11 | 7% |
| Asian | 11 | 7% |
| Other | 1 | 1% |
| More than one race | 5 | 3% |
| Ethnicity | ||
| Hispanic | 16 | 10% |
| Non-Hispanic | 147 | 90% |
| Health insurance | ||
| Private | 109 | 67% |
| Public | 13 | 8% |
| Medicaid | 10 | 6% |
| Medicare | 31 | 19% |
| Cancer type | ||
| Breast | 20 | 12% |
| Gastrointestinal | 26 | 16% |
| Genitourinary | 20 | 12% |
| Gynecologic | 3 | 2% |
| Hematologic | 21 | 13% |
| Sarcoma | 36 | 22% |
| Thoracic | 6 | 4% |
| Prostate | 11 | 7% |
| Head and neck | 9 | 6% |
| Other | 11 | 7% |
| Cancer stage | ||
| Non-stage IV/non-advanced | 63 | 39% |
| Stage IV/advanced | 95 | 58% |
| Unknown/N/A | 5 | 3% |
| Active treatment | ||
| Yes | 91 | 56% |
| No | 72 | 44% |
| Treatment received (current or prior) | ||
| Chemotherapy | 142 | 87% |
| Radiation | 78 | 48% |
| Surgery | 96 | 59% |
| Stem cell transplant | 9 | 6% |
| Targeted/immunotherapy | 19 | 12% |
| CBD use (current or prior) | ||
| Total | 66 | 40% |
| Sublingual oil/tincture | 32 | 20% |
| Inhaled/vaping | 3 | 2% |
| Oral/edible | 19 | 12% |
| Topical | 18 | 11% |
| Unknown/other | 11 | 7% |
| Medical cannabis use (current or prior) | ||
| Total | 75 | 46% |
| Sublingual oil/tincture | 20 | 12% |
| Inhaled/vaping | 30 | 18% |
| Smoking | 11 | 7% |
| Oral/edible | 29 | 18% |
| Topical | 0 | 0% |
| Unknown/other | 10 | 6% |